RxDoctor Payments Data

Amie Clarke

Medical · Raleigh, NCNPI 1720058126

Payments from drug & device makers

$5,911in general payments, 2019–2025

Across 365 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$825
  • Lilly USA, LLC$719
  • Novo Nordisk$692
  • Amgen$689
  • Pfizer$340
  • Boehringer Ingelheim$338
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,908100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,911 in reported general payments places this provider in the 90th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$38,897
Medicare patients
155
Services billed
828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$98,415
JardianceEmpagliflozin30$49,934
TrulicityDulaglutide19$46,565
MounjaroTirzepatide22$33,878
EliquisApixaban16$18,120
MyrbetriqMirabegron23$15,426
SynthroidLevothyroxine Sodium85$8,922
Breo ElliptaFluticasone/Vilanterol15$7,977
ArexvyRsvpref3 Antigen/As01e/Pf20$6,317
Levothyroxine Sodium233$3,316
SymbicortBudesonide/Formoterol Fumarate11$2,998
Gabapentin148$2,358
Atorvastatin Calcium221$2,197
Rosuvastatin Calcium194$1,967
Valsartan54$1,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$692$98,41559 claims
Lilly USA, LLCTrulicity, Mounjaro$719$80,44241 claims
Boehringer IngelheimJardiance$338$49,93430 claims
PfizerEliquis, Paxlovid$340$19,54934 claims
Astellas Pharma US IncMyrbetriq$127$15,42623 claims
GSKBreo Ellipta, Arexvy$57$14,29435 claims
AbbVieSynthroid$825$8,92285 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$43$3,316233 claims
AstraZenecaSymbicort$314$2,99811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 878 medical providers in North Carolina.

Other medical in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →